EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Leveraging AI-ECG Technology for Early Notification and Tracking of AF Development (LATENT): A Randomized Controlled Trial

Chiao-Chin Lee, Wen-Yu Lin, Wei-Ting Liu, Chiao-Hsiang Chang, Yu-Lan Liu, Da-Wei Chang, Pang-Yen Liu, Wen-Cheng Liu, YuChih Lin, Dung‑Jang Tsai, Kai-Chieh Chen, Tzu-Chiao Lin, Shu-Chen Chang, Hsin-Hui Chen, Wen-Hui Fang, Wei-Shiang Lin, Cheng-Chung Cheng, Kuan-Hsun Lin, Teng-Wei Chen, Chih-Yuan Lin, Yi-Ting Tsai, Yuan-Hao Chen, Chien-Sung Tsai, Shih-Hua Lin, C. Lin, C.-S. Lin

Circulation · 2026-11-07

DOI: 10.1161/circulationaha.126.083540 ↗
AbstractBibliografische Angaben

Abstract

BACKGROUND: Electrocardiographic analysis aided by artificial intelligence (AI) may identify atrial electrical vulnerability during sinus rhythm. The objective of this study was to determine whether AI–enabled ECG (AI-ECG) is effective for detecting atrial fibrillation (AF), atrial flutter (AFl), or prespecified pre-AF atrial findings in a randomized trial. METHODS: In this single-center, open-label trial, 14 665 adults 40 to 85 years of age without previous AF/AFl were randomized to an AI-ECG–guided strategy or usual care. Participants randomized to AI-ECG who were then identified by AI as having a high-risk sinus-rhythm ECG in the preceding year were offered Holter monitoring for ≤7 days. Each monitored high-risk intervention participant was paired with an age- and sex-matched control selected before control ECGs underwent AI analysis. Matched controls received identical monitoring to reduce ascertainment bias. Reporting cardiologists were blinded to AI results and randomized assignment. The primary outcome was a composite of newly detected AF, AFl, or pre-AF atrial findings within 90 days. Pre-AF atrial findings comprised frequent premature atrial complexes, short runs of premature atrial complexes, or nonsustained AF/AFl. RESULTS: Among 7337 intervention and 7328 control participants, 84 (1.1%) and 78 (1.1%), respectively, were classified as high risk. Of the 84 high-risk intervention participants, 48 (57.1%) underwent monitoring, as did 48 matched controls. The primary outcome occurred in 54 intervention participants (0.74%) versus 35 control participants (0.48%; odds ratio, 1.54 [95% CI, 1.01–2.37]; P =0.046). Hypothetical reclassification of 1 intervention event to a nonevent changed the primary analysis P value to 0.057. The intervention effect on detection of the primary composite outcome differed by baseline AI-ECG risk ( P interaction

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →